# OrbusNeich extends exclusive US distribution agreement with Abbott's CSI to 2027

OrbusNeich and Cardiovascular Systems Inc. (CSI), a subsidiary of Abbott Laboratories, amended their distribution agreement to extend OrbusNeich's appointment of CSI as exclusive distributor of coronary and peripheral balloon products in the US until December 31, 2027.

- Type: Contract
- Announced: 2023-09-27
- Where: United States
- Status: announced
- Products: coronary and peripheral balloon products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OrbusNeich Medical](https://endata.com/companies/69366.md)
- [Abbott Laboratories](https://endata.com/companies/20171.md) (partner)
- [Cardiovascular Systems](https://endata.com/companies/53965.md) (partner)

## Sources

- [orbusneich.com](https://orbusneich.com/orbusneich-extends-exclusive-u-s-distribution-agreement-with-abbott-laboratories-csi-until-end-of-2027/), 2023-09-27: "We are delighted to announce the extension of our exclusive distribution agreement with CSI, which will further strengthen our alliance with this partner."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.